Mark Shaves

Eastern Virginia Medical School, Sentara Norfolk General Hospital

Papers

Total Citations

155

H-Index

About

Mark Shaves is a urological researcher whose work has made meaningful contributions to the understanding of patient-centered outcomes in prostate cancer treatment. His research focuses primarily on health-related quality of life (HRQoL) following surgical and ablative interventions for localized prostate cancer, a field of growing importance as survival rates improve and long-term patient wellbeing becomes a central treatment consideration. His most influential publication, "Quality of Life After Open or Robotic Prostatectomy, Cryoablation or Brachytherapy for Localized Prostate Cancer" (2010), has garnered 103 citations and represents a landmark comparative analysis of HRQoL outcomes across four major treatment modalities. By prospectively tracking patients beginning in 2000, Shaves and colleagues provided clinicians with nuanced recovery profiles that directly inform shared decision-making between physicians and patients. His earlier work, recognized with a Fourth Prize distinction and accumulating 52 citations, further demonstrated his commitment to rigorous longitudinal methodology, evaluating five distinct surgical approaches within a single institution to minimize confounding variables. Taken together, Shaves's contributions offer clinicians and patients a clearer picture of the trade-offs between treatment options, ultimately elevating the standard of individualized, quality-conscious prostate cancer care.